Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Wistuba

Showing results (161-170 of 671) with videos related to

Pageof 68
Sort By:
Cancer Research|August 14, 1999
Multiple regions of chromosome 4 demonstrating allelic losses in breast carcinomasN Shivapurkar, S Sood, I I Wistuba, et al.
The American Journal of Pathology|July 5, 2001
High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele lossA Maitra, I I Wistuba, C Washington, et al.
Clinical Epigenetics|January 10, 2014
Decitabine impact on the endocytosis regulator RhoA, the folate carriers RFC1 and FOLR1, and the glucose transporter GLUT4 in human tumorsDavid J Stewart, Maria I Nunez, Jaroslav Jelinek, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Intratumoral epiregulin is a marker of advanced disease in non-small cell lung cancer patients and confers invasive properties on EGFR-mutant cellsJie Zhang, Kentaro Iwanaga, Kuicheon C Choi, et al.
Seminars in Respiratory and Critical Care Medicine|April 19, 2011
Evolving concepts in lung carcinogenesisBrigitte N Gomperts, Avrum Spira, Pierre P Massion, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2014
Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesotheliomaErick Riquelme, Milind B Suraokar, Jaime Rodriguez, et al.
Cancer Research|March 15, 2015
RSPO2 Enhances Canonical Wnt Signaling to Confer Stemness-Associated Traits to Susceptible Pancreatic Cancer CellsMatthias Ilmer, Alejandro Recio Boiles, Ivonne Regel, et al.
Gastrointestinal Cancer Research : GCR|March 6, 2009
HER Receptor Family: Novel Candidate for Targeted Therapy for Gallbladder and Extrahepatic Bile Duct CancerToru Kawamoto, Savitri Krishnamurthy, Emily Tarco, et al.
Cell Reports. Medicine|September 4, 2024
Loss of p53 and SMAD4 induces adenosquamous subtype pancreatic cancer in the absence of an oncogenic KRAS mutationDaowei Yang, Xinlei Sun, Rohan Moniruzzaman, et al.
Gastroenterology|March 11, 2024
Genetic Deletion of Galectin-3 Inhibits Pancreatic Cancer Progression and Enhances the Efficacy of ImmunotherapyDaowei Yang, Xinlei Sun, Rohan Moniruzzaman, et al.
Pageof 68

Showing results (161-170 of 671) with videos related to

Sort By:
Pageof 68
Cancer Research|August 14, 1999
Multiple regions of chromosome 4 demonstrating allelic losses in breast carcinomasN Shivapurkar, S Sood, I I Wistuba, et al.
The American Journal of Pathology|July 5, 2001
High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele lossA Maitra, I I Wistuba, C Washington, et al.
Clinical Epigenetics|January 10, 2014
Decitabine impact on the endocytosis regulator RhoA, the folate carriers RFC1 and FOLR1, and the glucose transporter GLUT4 in human tumorsDavid J Stewart, Maria I Nunez, Jaroslav Jelinek, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Intratumoral epiregulin is a marker of advanced disease in non-small cell lung cancer patients and confers invasive properties on EGFR-mutant cellsJie Zhang, Kentaro Iwanaga, Kuicheon C Choi, et al.
Seminars in Respiratory and Critical Care Medicine|April 19, 2011
Evolving concepts in lung carcinogenesisBrigitte N Gomperts, Avrum Spira, Pierre P Massion, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2014
Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesotheliomaErick Riquelme, Milind B Suraokar, Jaime Rodriguez, et al.
Cancer Research|March 15, 2015
RSPO2 Enhances Canonical Wnt Signaling to Confer Stemness-Associated Traits to Susceptible Pancreatic Cancer CellsMatthias Ilmer, Alejandro Recio Boiles, Ivonne Regel, et al.
Gastrointestinal Cancer Research : GCR|March 6, 2009
HER Receptor Family: Novel Candidate for Targeted Therapy for Gallbladder and Extrahepatic Bile Duct CancerToru Kawamoto, Savitri Krishnamurthy, Emily Tarco, et al.
Cell Reports. Medicine|September 4, 2024
Loss of p53 and SMAD4 induces adenosquamous subtype pancreatic cancer in the absence of an oncogenic KRAS mutationDaowei Yang, Xinlei Sun, Rohan Moniruzzaman, et al.
Gastroenterology|March 11, 2024
Genetic Deletion of Galectin-3 Inhibits Pancreatic Cancer Progression and Enhances the Efficacy of ImmunotherapyDaowei Yang, Xinlei Sun, Rohan Moniruzzaman, et al.
Pageof 68